08/14/2025
4:34 PM | Oric Pharmaceuticals (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
| Form SCHEDULE 13G/A | |
08/12/2025
3:20 PM | Oric Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/05/2025
5:36 PM | EcoR1 Capital, LLC (Filed by)
Oric Pharmaceuticals (Subject)
| Form SCHEDULE 13G | |
07/17/2025
6:54 PM | BlackRock, Inc. (Filed by)
Oric Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
06/24/2025
5:33 PM | Oric Pharmaceuticals (Issuer)
Piscitelli Dominic (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2025
3:05 PM | Oric Pharmaceuticals (Filer)
| Form 424B3 | |
06/23/2025
7:05 PM | Oric Pharmaceuticals (Issuer)
You Angie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2025
11:15 PM | Oric Pharmaceuticals (Filer)
| Form EFFECT | |
06/13/2025
6:38 PM | Oric Pharmaceuticals (Issuer)
Piscitelli Dominic (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
5:37 PM | Oric Pharmaceuticals (Issuer)
Piscitelli Dominic (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
7:18 PM | Oric Pharmaceuticals (Issuer)
Piscitelli Dominic (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for ORIC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Oric Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
06/06/2025
3:16 PM | Oric Pharmaceuticals (Subject)
Piscitelli Dominic (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/06/2025
11:22 AM | Oric Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
06/05/2025
4:17 PM | Oric Pharmaceuticals (Subject)
SR ONE CAPITAL MANAGEMENT, LLC (Filed by)
| Form SCHEDULE 13D | |
06/04/2025
3:32 PM | Oric Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SCHEDULE 13G | |
05/30/2025
3:35 PM | Oric Pharmaceuticals (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SCHEDULE 13G | |
05/28/2025
3:42 PM | Oric Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2025
4:47 PM | Oric Pharmaceuticals (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
05/15/2025
8:42 AM | Frazier Life Sciences Public Fund, L.P. (Filed by)
Oric Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
04/23/2025
3:10 PM | Oric Pharmaceuticals (Filer)
| Form DEFA14A | |
04/23/2025
3:15 PM | Oric Pharmaceuticals (Filer)
| Form ARS | |
03/20/2025
3:25 PM | Oric Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/04/2025
4:27 PM | Kunkel Lori Anne (Reporting)
Oric Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
8:30 AM | FMR LLC (Filed by)
Oric Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
01/13/2025
7:30 AM | Oric Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/06/2025
3:43 PM | Dier Mardi (Reporting)
Oric Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
3:44 PM | Heyman Richard A. (Reporting)
Oric Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
3:45 PM | Hoerter Steven L. (Reporting)
Oric Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
3:46 PM | Kunkel Lori Anne (Reporting)
Oric Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
3:47 PM | Oric Pharmaceuticals (Issuer)
You Angie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
4:41 PM | Chacko Jacob (Reporting)
Oric Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
4:41 PM | Oric Pharmaceuticals (Issuer)
Piscitelli Dominic (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
4:42 PM | Multani Pratik S (Reporting)
Oric Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
4:21 PM | Chacko Jacob (Reporting)
Oric Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
4:22 PM | Multani Pratik S (Reporting)
Oric Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
4:23 PM | Oric Pharmaceuticals (Issuer)
Piscitelli Dominic (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
8:31 PM | Chacko Jacob (Reporting)
Oric Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
8:34 PM | Multani Pratik S (Reporting)
Oric Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
8:29 PM | Oric Pharmaceuticals (Subject)
Piscitelli Dominic (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
4:54 PM | EcoR1 Capital, LLC (Filed by)
Oric Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/14/2024
4:47 PM | Nextech Crossover I GP S.a r.l. (Filed by)
Oric Pharmaceuticals (Subject)
| Form SC 13G/A | |
The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad) Something big is brewing in Washington.
According to my research, an executive order from President Trump could be just weeks away.
And it holds the potential to trigger one of the most explosive tech booms in US history.
At the center of it all? Robots.
Not the kind that clean your house or pour you coffee.
But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year. This little-known company holds nearly 100 patents and trades for around $7 |
11/13/2024
8:42 AM | ALKEON CAPITAL MANAGEMENT LLC (Filed by)
Oric Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/08/2024
1:17 PM | BlackRock, Inc. (Filed by)
Oric Pharmaceuticals (Subject)
| Form SC 13G | |
10/22/2024
5:06 PM | BlackRock, Inc. (Filed by)
Oric Pharmaceuticals (Subject)
| Form SC 13G | |
MarketBeat All Access